(Q40930326)

24 September 2017

title

MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition (English)

1 reference

24 September 2017

Liqun Zhang

1

1 reference

24 September 2017

Hongyu Quan

2

1 reference

24 September 2017

Sihai Wang

3

1 reference

24 September 2017

XueHui Li

4

1 reference

24 September 2017

Xiaoyu Che

5

1 reference

24 September 2017

publication date

17 May 2015

1 reference

24 September 2017

1 reference

24 September 2017

volume

36

1 reference

24 September 2017

issue

10

1 reference

24 September 2017

page(s)

8121-8126

1 reference

Mechanisms involved in lung cancer development in COPD.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

Small cell lung cancer: the importance of the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

SEMA4b inhibits MMP9 to prevent metastasis of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

SEMA4B inhibits growth of non-small cell lung cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

Targeting miR-21 for the therapy of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

Dysregulated miR-183 inhibits migration in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

MicroRNA-183 regulates Ezrin expression in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

The role of FoxO in the regulation of metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

IGF2R expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

Liver X receptor α inhibits osteosarcoma cell proliferation through up-regulation of FoxO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3550-8

Downregulation of miR-183 inhibits apoptosis and enhances the invasive potential of endometrial stromal cells in endometriosis

21 January 2018

1 reference

12 December 2020

In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors

1 reference

12 December 2020

miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells

1 reference

12 December 2020

Notch 3 protein, not its gene polymorphism, is associated with the chemotherapy response and prognosis of advanced NSCLC patients

1 reference

12 December 2020

10.1007/S13277-015-3550-8

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1049233885

0 references

1 reference